Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

HS-20094

Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity

Regeneron · Phase 2 · Not yet recruiting · Enrollment 300

NCT07830329

ArmPopulationDoseWeeksEstimandWeight change
OlatorepatideHidradenitis Suppurativan/rn/rn/rn/r
PlaceboHidradenitis Suppurativan/rn/rn/rn/r